CONSIDERATIONS TO KNOW ABOUT API PHARMACEUTICAL

“The current situation has uncovered some structural weaknesses while in the EU’s medicines provide chain plus a significant dependence on non-EU countries for active pharmaceutical ingredients,” Kyriakides explained. She proposed that offer chain problems be tackled within an EU pharmaceutical system anticipated to get launched by the end wi